SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease
Loren Laine(VA Connecticut Healthcare System), Yu‐Xiao Yang, Silvia Sanduleanu, Fernando Velayos, Alan Barkun(McGill University), Francis A. Farraye, Amandeep K. Shergill, Douglas Yakich, Thomas Ullman, Andrés Sánchez-Yagüe, Brian G. Feagan(Western University), David T. Rubin(University of California System), Matthew D. Rutter(Durham University), Ralf Kießlich(University Medical Center of the Johannes Gutenberg University Mainz), Tonya Kaltenbach(VA Palo Alto Health Care System), Robert D. Odze, John P. A. Ioannidis(Stanford University), Klaus Mönkemüller, Michael J. Krier, Carlos Rubio-Terrés, James E. East(John Radcliffe Hospital), Takayuki Matsumoto(Hoshi University)
Cited by 408
Related Papers
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
|Nature Reviews Genetics|2008|3k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
ACG Clinical Guideline: Ulcerative Colitis in Adults
|The American Journal of Gastroenterology|2019|1.6k